Mary Ann Checkley
- Virology top 1%
- HIV Research and Treatment 7
- Infectious Diseases top 5%
- HIV/AIDS Research and Interventions 2
- Antifungal resistance and susceptibility 2
- HIV/AIDS drug development and treatment 2
- Neurology top 10%
-
- Herpesvirus Infections and Treatments 2
- Fungal Infections and Studies 2
-
- Chromosomal and Genetic Variations 2
-
- Fungal and yeast genetics research 2
- Co-authors
- Benjamin G. LuttgeEric O. FreedDavid GarfinkelKatherine M. NyswanerKunio NagashimaJonathan KarnStephen LockettGary E. Landreth
- Cited by
- VirologyInfectious DiseasesNeurology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Molecular Biology (1 paper)Molecular and Cellular Biology (1 paper)
- Partner nations
- United StatesPolandJapan
In The Last Decade
Mary Ann Checkley
12 papers receiving 808 citations
Peers
Comparison fields: 5 of 79
- Virology 435
- Infectious Diseases 247
- Neurology 88
- Immunology 201
- Biological Psychiatry 14
Countries citing papers authored by Mary Ann Checkley
This map shows the geographic impact of Mary Ann Checkley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ann Checkley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ann Checkley more than expected).
Fields of papers citing papers by Mary Ann Checkley
This network shows the impact of papers produced by Mary Ann Checkley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ann Checkley. The network helps show where Mary Ann Checkley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary Ann Checkley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2016 | 133 | |
| 3 | 2016 | 45 | |
| 4 | 2013 | 5 | |
| 5 | 2013 | 28 | |
| 6 | 2012 | 22 | |
| 7 | 2011 | 332 | |
| 8 | 2010 | 50 | |
| 9 | 2009 | 62 | |
| 10 | 2008 | 63 | |
| 11 | 2005 | 18 | |
| 12 | 2003 | 53 |
About Mary Ann Checkley
Mary Ann Checkley is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 12 papers that have together received 814 indexed citations. Recurring topics across this work include HIV Research and Treatment (7 papers), Herpesvirus Infections and Treatments (2 papers), HIV/AIDS Research and Interventions (2 papers), Antifungal resistance and susceptibility (2 papers), Chromosomal and Genetic Variations (2 papers), Fungal Infections and Studies (2 papers), Fungal and yeast genetics research (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Virology (435 citations), Infectious Diseases (247 citations) and Neurology (88 citations). Mary Ann Checkley has collaborated with scholars based in United States, Poland and Japan. Frequent co-authors include Benjamin G. Luttge, Eric O. Freed, David Garfinkel, Katherine M. Nyswaner, Kunio Nagashima, Jonathan Karn, Stephen Lockett, Gary E. Landreth, Saba Valadkhan and Curtis Dobrowolski. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.